UR
BNGO icon

USCA RIA’s Bionano Genomics BNGO Stock Holding History

USCA RIA’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$73K Buy
+17
New +$67.1K ﹤0.01% 564

Other funds holding BNGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

USCA RIA's BNGO Position: Q2 2021 in Review

USCA RIA opened a new position in Bionano Genomics (BNGO) in Q2 2021: 17 shares worth $73K. The stake represents ﹤0.01% of the portfolio and ranks #564 among its holdings.

152 funds tracked by Wall St. Rank hold BNGO as of Q2 2021.

  • USCA RIA held 17 shares of Bionano Genomics worth $73K as of Q2 2021.
  • Bionano Genomics was a new USCA RIA position in Q2 2021.
  • Bionano Genomics made up ﹤0.01% of USCA RIA's portfolio in Q2 2021, its #564 holding.
  • 152 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2021.

Based on USCA RIA's 13F filing for Q2 2021, filed 28 Jul 2021.